Ig Glycosylation in Ulcerative Colitis: It’s Time for New Biomarkers

Background: Ulcerative colitis (UC) is a chronic relapsing disease, which needs a continue monitoring, especially during biological therapies. An increasing number of patients is treated with anti-Tumor Necrosis factor (TNF) drugs, and current research is focalized to identify biomarkers able to mon...

Descripción completa

Detalles Bibliográficos
Autores principales: Capecchi, Riccardo, Migliorini, Paola, Zanzi, Federico, Maltinti, Simona, Puxeddu, Ilaria, de Bortoli, Nicola, Bellini, Massimo, Costa, Francesco, Marchi, Santino, Bertani, Lorenzo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8062917/
https://www.ncbi.nlm.nih.gov/pubmed/33897440
http://dx.doi.org/10.3389/fphar.2021.654319

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8062917/
https://www.ncbi.nlm.nih.gov/pubmed/33897440
http://dx.doi.org/10.3389/fphar.2021.654319

Ejemplares similares